Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species

JD Sobel, R Sobel - Expert opinion on pharmacotherapy, 2018 - Taylor & Francis
Introduction: Clinicians are increasingly challenged by patients with refractory vulvovaginal
candidiasis (VVC) caused by azole-resistant Candida species. Fluconazole resistant C …

Recent advances in delivery of antifungal agents for therapeutic management of candidiasis

B Sawant, T Khan - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Candidiasis is a fungal infection caused by yeasts that belong to the genus Candida. There
are over twenty species of Candida yeasts that can cause infection in humans, the most …

Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America

E Martinez-Herrera, MG Frias-De-Leon… - Journal of Fungi, 2021 - mdpi.com
In different regions worldwide, there exists an intra-and inter-regional variability in the rates
of resistance to antifungal agents in Candida glabrata, highlighting the importance of …

The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon

NF Ambe, NA Longdoh, P Tebid, TP Bobga… - Pan African Medical …, 2020 - ajol.info
Introduction: oral candidiasis is one of the most common opportunistic infection in HIV/AIDS
patient and it is caused by Candida species. The low absolute CD4+ T-lymphocyte count …

Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome

J Zhong, Y Liu, N Luo, Q Wei, Q Su, J Zou, X Wu… - Annals of Clinical …, 2023 - Springer
Background Acquired immunodeficiency syndrome (AIDS) is associated with a high rate of
pulmonary infections (bacteria, fungi, and viruses). To overcome the low sensitivity and long …

[HTML][HTML] Comparison of the clinical features of HIV-positive and HIV-negative hosts infected with Talaromyces marneffei: a multicenter, retrospective study

Y Qiu, AL Liu, J Huang, W Zeng, ZM Yang… - International Journal of …, 2023 - Elsevier
Objectives Talaromyces marneffei is an emerging pathogen, and the number of infections in
HIV-negative individuals is rapidly increasing. Nevertheless, there is no sufficient …

Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms

R Ghasemi, E Lotfali, K Rezaei, SA Madinehzad… - Brazilian Journal of …, 2022 - Springer
Meyerozyma guilliermondii has been accepted as a complex composed of Meyerozyma
guilliermondii, Meyerozyma carpophila, and Meyerozyma caribbica. M. guilliermondii is a …

Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth

RU Pathirana, AD McCall, HL Norris… - Frontiers in …, 2019 - frontiersin.org
Non-albicans Candida species (NACS) are often isolated along with Candida albicans in
cases of oropharyngeal candidiasis. C. albicans readily forms biofilms in conjunction with …

Interactions between Candida albicans and Candida glabrata in biofilms: Influence of the strain type, culture medium and glucose supplementation

TY Hosida, TP Cavazana, M Henriques, JP Pessan… - Mycoses, 2018 - Wiley Online Library
The relationship among Candida species may be influenced by several factors. Thus, this
study evaluated the interactions between Candida albicans and Candida glabrata in …

[HTML][HTML] Phytochemistry, antifungal and antioxidant activity, and cytotoxicity of Byrsonima gardneriana (A. Juss) extract

WO de Souza-Melo, EC Figueiredo-Júnior… - Archives of Oral …, 2021 - Elsevier
Objective To determine the phytochemical composition of Byrsonima gardneriana (A. Juss)
leaf extract (BGE) and its antifungal activity against Candida spp., antioxidant potential and …